Tag: Biogen
Researchers shed new light on treatment of Alzheimer’s disease
According to Alzheimer 's Disease International, more than 55 million people worldwide will have Alzheimer's disease by 2020. This figure will nearly double every...
Eisai files for approval of Alzheimer’s drug in Europe
Japanese drugmaker Eisai said on Tuesday (January 10) it had submitted a marketing application to the European health regulator for review of its Alzheimer's...
Eisai, Biogen Alzheimer’s disease drug could be available to some as early as next year
Japanese pharmaceutical firm Eisai Co plans to seek full approval of its experimental Alzheimer's drug lecanemab in the United States, Europe and Japan armed with...